Medico Remedies Ltd
Incorporated in 1994, Medico Remedies Ltd manufactures and sells pharmaceutical formulations[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
Ratios
Figures in Rs. Crores
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Documents
Announcements
-
Board Meeting Outcome for Outcome
14 Nov - Board approved unaudited Q2/H1 results to 30 Sep 2025; H1 net profit Rs438.63 lakh.
-
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015- Issuance Of GMP Compliance Certificate By The State Service Of Ukraine On Medicines And Drugs Control
14 Nov - SMDC issued GMP compliance certificate to Palghar Facility on 10 Nov 2025, enabling access to PIC/S-regulated markets.
-
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
7 Nov - Medico Remedies secured USD 1,116,517 government supply order from PROMESE/CAL; delivery within 3 months.
-
Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended 30Th September 2025
6 Nov - Board meeting 14 Nov 2025 to approve unaudited Q2 (30 Sep 2025) results with limited review.
-
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
6 Oct - 6 Oct 2025: Medico won USD 1,781,000 Turkmenistan government order to supply tablets, capsules, dry syrups.
Business Overview:[1][2]
MRL is a pharmaceutical formulation manufacturing and marketing company with focus on antibiotic, anti-infective, beta-lactam penicillin, cephalosporin, anti fungal, antimalarial, antiretroviral, anti-ulcer drugs and antacids, vitamins & supplements, hematinic and other drugs viz. NSAIDS, antihistaminic, anti-diabetics, cardiovascular drugs, antipyretic, analgesic, diuretics, anti-epileptics, antidepressants, antipsychotics, combination drug kits, dry syrups, ointments and cream & gel for various therapeutic segments